Rapid communication Open Access
Like 0


is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). should be considered in patients with respiratory symptoms, especially children.


Article metrics loading...

Loading full text...

Full text loading...



  1. de Groot RCA, Meyer Sauteur PM, Unger WWJ, van Rossum AMC. Things that could be Mycoplasma pneumoniae. J Infect. 2017;74(Suppl 1):S95-100.  https://doi.org/10.1016/S0163-4453(17)30198-6  PMID: 28646969 
  2. Søndergaard MJ, Friis MB, Hansen DS, Jørgensen IM. Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One. 2018;13(4):e0195288.  https://doi.org/10.1371/journal.pone.0195288  PMID: 29698412 
  3. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697-728.  https://doi.org/10.1128/CMR.17.4.697-728.2004  PMID: 15489344 
  4. Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, et al. Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021. Euro Surveill. 2022;27(19):2100746.  https://doi.org/10.2807/1560-7917.ES.2022.27.19.2100746  PMID: 35551702 
  5. Fourie E, Bording ES, Euser SM, Badoux P, Haverkort ME, van Houten MA. Nasal discharge: A unique enhanced alternative for the detection of respiratory pathogens in adults. J Med Virol. 2023;95(8):e29047.  https://doi.org/10.1002/jmv.29047  PMID: 37621163 
  6. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Virologische weekstaten. [Weekly virological statistics]. Bilthoven: RIVM. [Accessed: 15 December 2023]. Dutch. Available from: https://www.rivm.nl/virologische-weekstaten
  7. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Infectieradar. [Infection radar]. Bilthoven: RIVM. [Accessed: 19 December 2023]. Dutch. Available from: https://www.infectieradar.nl/about
  8. PathoFinder. PathoFinder B.V.; 2021, Available from: https://www.pathofinder.com/2smart-products/pf2600-2s
  9. Reukers D, van Asten L, Brandsema P, Dijkstra F, Hendriksen J, van der Hoek W, et al. Annual report. Surveillance of influenza and other respiratory infections in the Netherlands: winter 2019/2020. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2021. Available from: https://www.rivm.nl/bibliotheek/rapporten/2020-0177.pdf
  10. Brandsema P, Dijkstra F, Euser S, van Gageldonk-Lafeber A, de Lange M, Meijer A, et al. Jaarrapportage surveillance respiratoire infectieziekten 2011. [Annual report surveillance respiratory infectious diseases 2011]. Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2012. Dutch. Available from: https://www.rivm.nl/bibliotheek/rapporten/201041001.html
  11. Meyer Sauteur PM, Beeton ML, Pereyre S, Bébéar C, Gardette M, Hénin N, et al. Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions. Lancet Microbe. 2023;S2666-5247(23)00344-0.  https://doi.org/10.1016/S2666-5247(23)00344-0  PMID: 38008103 
  12. Nordholm AC, Søborg B, Jokelainen P, Lauenborg Møller K, Flink Sørensen L, Grove Krause T, et al. Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023. Euro Surveill. 2024;29(2):2300707.  https://doi.org/10.2807/1560-7917.ES.2024.29.2.2300707  PMID: 38214084 
  13. Omori R, Nakata Y, Tessmer HL, Suzuki S, Shibayama K. The determinant of periodicity in Mycoplasma pneumoniae incidence: an insight from mathematical modelling. Sci Rep. 2015;5(1):14473.  https://doi.org/10.1038/srep14473  PMID: 26412506 
  14. Oster Y, Michael-Gayego A, Rivkin M, Levinson L, Wolf DG, Nir-Paz R. Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures? Clin Microbiol Infect. 2020;27(5):811-2.  https://doi.org/10.1016/j.cmi.2020.12.007  PMID: 33352303 
  15. Cohen R, Levy C, Rybak A, Angoulvant F, Ouldali N, Grimprel E. Immune debt: Recrudescence of disease and confirmation of a contested concept. Infect Dis Now. 2023;53(2):104638.  https://doi.org/10.1016/j.idnow.2022.12.003  PMID: 36535583 
  16. Reukers D, van Asten L, Hooiveld M, Jongenotter F, de Lange M, Teirlinck A, et al. Surveillance van acute luchtweginfecties in Nederland: winter 2022/2023. [Surveillance of acute respiratory infections in the Netherlands: winter 2022/2023. SARS-CoV-2, influenza virus, RSV and other respiratory viruses.] Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu; 2023. Dutch. Available from: https://www.rivm.nl/bibliotheek/rapporten/2023-0378.pdf
  17. European Centre for Disease Prevention and Control (ECDC). Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations 2023. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/en/news-events/acute-respiratory-infections-eueea-epidemiological-update-and-current-public-health
  18. World Health Organization (WHO). Upsurge of respiratory illnesses among children-Northern China. Geneva: WHO; 2023. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494
  19. Wiersinga WJ, Bonten MJ, Boersma WG, Jonkers RE, Aleva RM, Kullberg BJ, et al. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth J Med. 2018;76(1):4-13. PMID: 29380739 
  20. Pereyre S, Goret J, Bébéar C. Mycoplasma pneumoniae: current knowledge on macrolide resistance and treatment. Front Microbiol. 2016;7:974.  https://doi.org/10.3389/fmicb.2016.00974  PMID: 27446015 
  21. Schroeder MR, Stephens DS. Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98.  https://doi.org/10.3389/fcimb.2016.00098  PMID: 27709102 
  22. Smith MJ. Macrolides and pediatric community-acquired pneumonia-time for a paradigm shift? JAMA Pediatr. 2017;171(12):1147-8.  https://doi.org/10.1001/jamapediatrics.2017.3828  PMID: 29084314 
  23. Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5):e1001444.  https://doi.org/10.1371/journal.pmed.1001444  PMID: 23690754 
  24. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. . Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835-45.  https://doi.org/10.1056/NEJMoa1405870  PMID: 25714161 
  25. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. . Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415-27.  https://doi.org/10.1056/NEJMoa1500245  PMID: 26172429 

Data & Media loading...

Supplementary data

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error